BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27965189)

  • 1. Magnesium, C-reactive protein, and cortisol in drug-naïve patients with short illness-duration, first episode major depressive disorder: possible immunomodulatory role for magnesium.
    Cubała WJ; Landowski J; Dziadziuszko M; Chrzanowska A; Wielgomas B
    Magnes Res; 2016 Apr; 29(4):169-174. PubMed ID: 27965189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein and cortisol in drug-naïve patients with short-illness-duration first episode major depressive disorder: possible role of cortisol immunomodulatory action at early stage of the disease.
    Cubała WJ; Landowski J
    J Affect Disord; 2014 Jan; 152-154():534-7. PubMed ID: 24161452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium in drug-naïve patients with a short-duration, first episode of major depressive disorder: impact on psychopathological features.
    Cubała WJ; Landowski J; Szyszko M; Czarnowski W
    Magnes Res; 2013; 26(4):192-8. PubMed ID: 24509052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein: A differential biomarker for major depressive disorder and bipolar II disorder.
    Chang HH; Wang TY; Lee IH; Lee SY; Chen KC; Huang SY; Yang YK; Lu RB; Chen PS
    World J Biol Psychiatry; 2017 Feb; 18(1):63-70. PubMed ID: 26895280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RELATIONSHIP BETWEEN THE CORTICAL THICKNESS AND SERUM CORTISOL LEVELS IN DRUG-NAÏVE, FIRST-EPISODE PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A SURFACE-BASED MORPHOMETRIC STUDY.
    Liu X; Kakeda S; Watanabe K; Yoshimura R; Abe O; Ide S; Hayashi K; Katsuki A; Umeno-Nakano W; Watanabe R; Ueda I; Moriya J; Nakamura J; Korogi Y
    Depress Anxiety; 2015 Sep; 32(9):702-8. PubMed ID: 26290363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentrations of CRP, IL-6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features.
    Karlović D; Serretti A; Vrkić N; Martinac M; Marčinko D
    Psychiatry Res; 2012 Jun; 198(1):74-80. PubMed ID: 22386567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low baseline salivary 3-methoxy-4-hydroxyphenylglycol (MHPG) in drug-naïve patients with short-illness-duration first episode major depressive disorder.
    Cubała WJ; Landowski J; Wielgomas B; Czarnowski W
    J Affect Disord; 2014 Jun; 161():4-7. PubMed ID: 24751300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary 5-hydroxyindole acetic acid (5-HIAA) in drug-naïve patients with short-illness-duration first episode major depressive disorder.
    Cubala WJ; Landowski J; Chrzanowska A
    Neuro Endocrinol Lett; 2014; 35(8):746-9. PubMed ID: 25702305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low baseline salivary alpha-amylase in drug-naïve patients with short-illness-duration first episode major depressive disorder.
    Cubała WJ; Landowski J
    J Affect Disord; 2014 Mar; 157():14-7. PubMed ID: 24581822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin response to buspirone is not impaired in drug-naïve first episode patients with major depressive disorder.
    Cubała WJ; Landowski J
    J Affect Disord; 2014 Jan; 152-154():468-73. PubMed ID: 24035672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc in drug-naïve patients with short-illness-duration first episode major depressive disorder: impact on psychopathological features.
    Cubala WJ; Landowski J; Szyszko M; Wielgomas B
    Neuro Endocrinol Lett; 2014; 35(8):741-5. PubMed ID: 25702304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in serum testosterone and cortisol in patients with major depressive disorder compared with controls.
    Matsuzaka H; Maeshima H; Kida S; Kurita H; Shimano T; Nakano Y; Baba H; Suzuki T; Arai H
    Int J Psychiatry Med; 2013; 46(2):203-21. PubMed ID: 24552043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between the hippocampal shape abnormality and serum cortisol levels in first-episode and drug-naïve major depressive disorder patients.
    Watanabe R; Kakeda S; Watanabe K; Liu X; Katsuki A; Umeno-Nakano W; Hori H; Abe O; Yoshimura R; Korogi Y
    Depress Anxiety; 2017 May; 34(5):401-409. PubMed ID: 28129464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of gut microbiota and its correlation with hs-CRP and somatic symptoms in first-episode treatment-naive major depressive disorder.
    Liu P; Jing L; Guo F; Xu Y; Cheng J; Liu S; Liu L; Liu Z; Zhang K; Sun N
    J Affect Disord; 2024 Jul; 356():664-671. PubMed ID: 38615845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serum magnesium concentration as a potential state marker in patients with unipolar affective disorder.
    Styczeń K; Siwek M; Sowa-Kućma M; Dudek D; Reczyński W; Szewczyk B; Misztak P; Topór-Mądry R; Opoka W; Nowak G
    Psychiatr Pol; 2015; 49(6):1265-76. PubMed ID: 26909401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin and depressive symptoms in patients with first-episode drug-naïve major depressive disorder: The mediating role of hypothalamic-pituitary-adrenal axis.
    Zhang C; Dong Y; Li S; Li M; Gao Y; Liu Y; Liu X; Zhou C; Li J
    Asia Pac Psychiatry; 2024 Mar; 16(1):e12552. PubMed ID: 38348641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of serum cortisol level with severity of depression and improvement in newly diagnosed patients with major depressive disorder in Jimma medical center, Southwest Ethiopia.
    Alenko A; Markos Y; Fikru C; Tadesse E; Gedefaw L
    PLoS One; 2020; 15(10):e0240668. PubMed ID: 33064754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota and inflammatory factor characteristics in major depressive disorder patients with anorexia.
    Guo F; Jing L; Xu Y; Zhang K; Li Y; Sun N; Liu P; Zhang H
    BMC Psychiatry; 2024 May; 24(1):334. PubMed ID: 38698338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study.
    Kuwano N; Kato TA; Setoyama D; Sato-Kasai M; Shimokawa N; Hayakawa K; Ohgidani M; Sagata N; Kubo H; Kishimoto J; Kang D; Kanba S
    J Affect Disord; 2018 Apr; 231():74-82. PubMed ID: 29454180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain structural network alterations related to serum cortisol levels in drug-naïve, first-episode major depressive disorder patients: a source-based morphometric study.
    Nguyen L; Kakeda S; Watanabe K; Katsuki A; Sugimoto K; Igata N; Shinkai T; Abe O; Korogi Y; Ikenouchi A; Yoshimura R
    Sci Rep; 2020 Dec; 10(1):22096. PubMed ID: 33328539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.